Marked Chart Marked Chart Closed

The Marked Chart Wire · Business

Novo Nordisk

Novo Nordisk lifts full-year outlook on strong Wegovy pill sales

Novo Nordisk reported quarterly earnings that exceeded expectations, driven by Wegovy pill sales that surpassed estimates. The company subsequently raised its full-year financial outlook.

NVO-0.6%

Illustration for the Business desk

The stocks in this story

  1. NVO-0.6%Novo Nordisk A/S$40.19

Prices from Before the open · based on Tue close · Opens 9:30 AM ET. Each tile opens the stock's chart and news.

New to this? Read: Reading a stock chart

More Business news

Illustration for the Business desk

Novo Nordisk

Novo Nordisk shares rise on strong Wegovy pill sales

Novo Nordisk shares climbed 6 percent after the company reported quarterly earnings that exceeded expectations. Sales of its Wegovy pill surpassed estimates, prompting the drugmaker to raise its outlook.

NVO-0.6%

Fast headlines, summarized. Not verified and not advice. Check the full story before you act.